Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,452 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,433
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.1%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 601–650 of 1,784 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05327270	Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions	active not recruiting	Phase 1	18	M.D. Anderson Cancer CenterOTHER	1	Jun 12, 2026	clinicaltrials
NCT05639972	E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers	recruiting	Phase 1 / Phase 2	15	Christian HinrichsOTHER	1	Jun 12, 2026	clinicaltrials